Epigenetic reprogramming as a key contributor to melanocyte malignant transformation
Open Access
- 1 April 2011
- journal article
- research article
- Published by Taylor & Francis in Epigenetics
- Vol. 6 (4) , 450-464
Abstract
Melanoma progression requires deregulation of gene expression by currently uncharacterized epigenetic mechanisms. A mouse model based on changes in cell microenvironment was developed by our group to study melanocyte malignant transformation. Melanoma cell lines (4C11- and 4C11+) were obtained as result of 5 sequential anchorage blockades of non-tumorigenic melan-a melanocytes. Melan-a cells submitted to 4 de-adhesion cycles were also established (4C), are non-tumorigenic and represent an intermediary phase of tumor progression. The aim of this work was to identify factors contributing to epigenetic modifications in early and later phases of malignant transformation induced by anchorage impediment. Epigenetic alterations occur early in tumorigenesis; 4C cell line shows changes in global and gene-specific DNA methylation and histone marks. Many histone modifications differ between melan-a, 4C, 4C11- (non-metastatic melanoma cell line) and 4C11+ (metastatic melanoma cell line) which could be associated with changes in gene and microRNA expression. These epigenetic alterations seem to play a key role in malignant transformation since melanocytes treated with 5-Aza-2'-deoxycytidine before each anchorage blockade do not transform. Some epigenetic changes seem to be also responsible for the maintenance of malignant phenotype, since melanoma cell lines (4C11- and 4C11+) treated in vitro with 5-Aza-2'-deoxycytidine or Trichostatin A showed reduction of tumor growth in vivo. Changes in gene expression reflecting cell adaptation to new environment were also observed. We propose a model in which sustained microenvironmental stress in melanocytes results in epigenetic reprogramming. Thus, after adaptation, cells may acquire epigenetic marks that could contribute to the establishment of a malignant phenotype.Keywords
This publication has 58 references indexed in Scilit:
- SIRT1 and p53, effect on cancer, senescence and beyondBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- DNA methylation and methyl-CpG binding proteins: developmental requirements and functionChromosoma, 2009
- Melanoma EpidemiologyHematology/Oncology Clinics of North America, 2009
- High‐temperature beverages and foods and esophageal cancer risk—A systematic reviewInternational Journal of Cancer, 2009
- G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcriptionThe EMBO Journal, 2008
- Genome-wide maps of chromatin state in pluripotent and lineage-committed cellsNature, 2007
- Stability and flexibility of epigenetic gene regulation in mammalian developmentNature, 2007
- A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem CellsCell, 2006
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004
- Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colonNature Genetics, 1994